Retrospective study finds the UA/Cr ratio associates with elevated PTH levels in adults without known parathyroid disease, suggesting a broader metabolic context.
Background: Parathyroid hormone (PTH) is mainly regulated by calcium, vitamin D, and renal function, but metabolic factors may also influence its levels. The uric acid/creatinine (UA/Cr) ratio reflects uric acid metabolism and renal handling. This study evaluated its association with elevated PTH in adults without known parathyroid disease. Methods: This retrospective cross-sectional study included 244 adults undergoing routine biochemical evaluation. The uric acid-to-creatinine ratio (UA/Cr) was calculated. Participants were categorized according to PTH levels (≤65 pg/mL vs. >65 pg/mL). Logistic regression analyses were performed to identify factors associated with elevated PTH levels. Results: A total of 244 individuals (mean age 40.6 ± 11.7 years; 70.9% female) were included in the analysis. Participants with elevated PTH levels had significantly higher UA/Cr ratios compared with those with normal PTH levels (8.93 ± 1.82 vs. 7.47 ± 1.79, p = 0.031). In univariate logistic regression analysis, UA/Cr was associated with elevated PTH (OR 1.15, 95% CI 1.01–1.32, p = 0.043). In multivariable logistic regression analysis adjusting for vitamin D, magnesium, phosphorus, corrected calcium, age, sex, body mass index, and the estimated glomerular filtration rate, the UA/Cr ratio remained significantly associated with elevated PTH levels (OR 1.41, 95% CI 1.036–1.66, p = 0.024). Conclusions: The UA/Cr ratio was associated with elevated PTH levels in adults without known parathyroid disease, independently of vitamin D status, mineral metabolism parameters, and renal function. These findings suggest that the UA/Cr ratio may help characterize a broader metabolic context associated with elevated PTH levels, rather than serving as a diagnostic marker. Further prospective studies are needed to clarify the clinical relevance and direction of this association.
No takes yet. Share an insight, caveat, or question.
ÖZDEMİR et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: